168 related articles for article (PubMed ID: 1422570)
1. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats.
Hovinga S; Stijnen AM; Langemeijer MW; Mandema JW; van Bezooijen CF; Danhof M
Br J Pharmacol; 1992 Sep; 107(1):171-7. PubMed ID: 1422570
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.
Mandema JW; Tukker E; Danhof M
Br J Pharmacol; 1991 Mar; 102(3):663-8. PubMed ID: 1364836
[TBL] [Abstract][Full Text] [Related]
3. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam.
Albrecht S; Ihmsen H; Hering W; Geisslinger G; Dingemanse J; Schwilden H; Schüttler J
Clin Pharmacol Ther; 1999 Jun; 65(6):630-9. PubMed ID: 10391668
[TBL] [Abstract][Full Text] [Related]
4. Effect of 7-day exposure to midazolam on electroencephalogram pharmacodynamics in rats: a model to study multiple pharmacokinetic-pharmacodynamic relationships in individual animals.
Laurijssens BE; Greenblatt DJ
J Pharm Pharmacol; 2002 Jan; 54(1):77-86. PubMed ID: 11829133
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of midazolam and metabolites in nonventilated infants after craniofacial surgery.
Peeters MY; Prins SA; Knibbe CA; Dejongh J; Mathôt RA; Warris C; van Schaik RH; Tibboel D; Danhof M
Anesthesiology; 2006 Dec; 105(6):1135-46. PubMed ID: 17122576
[TBL] [Abstract][Full Text] [Related]
6. Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol.
Tuk B; van Gool T; Danhof M
J Pharmacokinet Pharmacodyn; 2002 Jun; 29(3):235-50. PubMed ID: 12449497
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats.
Cox EH; Van Hemert JG; Tukker EJ; Danhof M
J Pharmacol Toxicol Methods; 1997 Oct; 38(2):99-108. PubMed ID: 9403781
[TBL] [Abstract][Full Text] [Related]
8. Increased sensitivity to the anesthetic effect of phenobarbital in aging BN/BiRij rats.
Stijnen AM; Danhof M; Van Bezooijen CF
J Pharmacol Exp Ther; 1992 Apr; 261(1):81-7. PubMed ID: 1560386
[TBL] [Abstract][Full Text] [Related]
9. Rate of change of blood concentrations is a major determinant of the pharmacodynamics of midazolam in rats.
Cleton A; Mazee D; Voskuyl RA; Danhof M
Br J Pharmacol; 1999 May; 127(1):227-35. PubMed ID: 10369477
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo.
Hoyo-Vadillo C; Mandema JW; Danhof M
Life Sci; 1995; 57(4):325-33. PubMed ID: 7603305
[TBL] [Abstract][Full Text] [Related]
11. Adaptive changes in the pharmacodynamics of midazolam in different experimental models of epilepsy: kindling, cortical stimulation and genetic absence epilepsy.
Cleton A; Voskuyl RA; Danhof M
Br J Pharmacol; 1998 Oct; 125(4):615-20. PubMed ID: 9831893
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic modelling of the interaction between flumazenil and midazolam in volunteers by aperiodic EEG analysis.
Breimer LT; Burm AG; Danhof M; Hennis PJ; Vletter AA; de Voogt JW; Spierdijk J; Bovill JG
Clin Pharmacokinet; 1991 Jun; 20(6):497-508. PubMed ID: 2044333
[TBL] [Abstract][Full Text] [Related]
13. Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling.
Breimer LT; Hennis PJ; Burm AG; Danhof M; Bovill JG; Spierdijk J; Vletter AA
Clin Pharmacokinet; 1990 Mar; 18(3):245-53. PubMed ID: 2323155
[TBL] [Abstract][Full Text] [Related]
14. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil.
Mandema JW; Tukker E; Danhof M
J Pharmacol Exp Ther; 1992 Jan; 260(1):36-44. PubMed ID: 1309878
[TBL] [Abstract][Full Text] [Related]
15. A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the rat.
Aarons L; Mandema JW; Danhof M
J Pharmacokinet Biopharm; 1991 Oct; 19(5):485-96. PubMed ID: 1783988
[TBL] [Abstract][Full Text] [Related]
16. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship.
Mandema JW; Kuck MT; Danhof M
Br J Pharmacol; 1992 Jan; 105(1):164-70. PubMed ID: 1350744
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats: assessment of rapid functional adaptation.
Cox EH; Kuipers JA; Danhof M
Br J Pharmacol; 1998 Aug; 124(7):1534-40. PubMed ID: 9723968
[TBL] [Abstract][Full Text] [Related]
18. In vivo modeling of the pharmacodynamic interaction between benzodiazepines which differ in intrinsic efficacy.
Mandema JW; Kuck MT; Danhof M
J Pharmacol Exp Ther; 1992 Apr; 261(1):56-61. PubMed ID: 1560385
[TBL] [Abstract][Full Text] [Related]
19. [RO 48-6791--a short acting benzodiazepine. Pharmacokinetics and pharmacodynamics in young and old subjects in comparison to midazolam].
Hering W; Ihmsen H; Albrecht S; Schwilden H; Schüttler J
Anaesthesist; 1996 Dec; 45(12):1211-4. PubMed ID: 9065257
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
